2Andrade RJ,Lucena MI,Alonso A,et al.HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease[J].Hepatology,2004,39(6): 1603.
7SGRO C,CLIMARD F,OUAZIR K ,et al. Incidence of drug-induced hepatic injuries:a French population-based study[J]. Hepatology, 2002,36 (2) : 451-455.
8MARIA VA,VICTORINO RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis[J]. Hepatology, 1997,26 : 664-669.
9DANAN G,BENICHOU C. Causality assessment of adverse reactions to drug-I. A novel method based on the conclusions of international consensus meetings:application to drug-induced liver injuries [J]. J Clin Epidemiol,1993,46: 1323-1330.
10ACHARYA SK,PANDA SK,SAXENA A,et al. Acute hepatic failure in India: a Perspective from the East [J]. J Gastroenterol Hepatol, 2000,15 (5) : 473-479.
9Expert Committee on Clinical Application of Glycyrrhizin Preparation in the Treatment of Liver Diseases.甘草酸制剂肝病临床应用专家共识[J].临床肝胆病杂志,2016,32(5):844-852. 被引量:54